ACEM26 Logo
  • 00Days
  • 00Hrs
  • 00Mins
  • 00Secs
Submit an abstract
ACEM 2025

CSL Seqirus

  • Booth no: 28

CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people.

Share

Key dates

  • Abstract Submissions Open

    16 March

  • Early Bird Registrations Open

    24 April

  • Abstract Submissions Close

    1 July

  • Abstract Acceptance Notification

    Late August

  • Volunteer Applications Close

    26 August

  • Presenter Acceptance Deadline

    Early September

  • Early Bird Registration Deadline

    7 September

  • Presenter Registration Deadline

    Late September

  • Standard Registration Deadline

    6 November

Related